Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-α in carcinoid tumor cells

被引:0
|
作者
Zhou, Y [1 ]
Wang, S [1 ]
Gobl, A [1 ]
Oberg, K [1 ]
机构
[1] Univ Uppsala Hosp, Endocrine Oncol Unit, S-75185 Uppsala, Sweden
关键词
interferon alpha; carcinoid tumor; cell cycle; p27kip1; cyclin dependent kinase; immunodepletion;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IFN-alpha has presented antitumor effect in about 50% of carcinoid tumor patients, though the antitumor mechanism of IFN-alpha is still to be elucidated. In this study we demonstrated that IFN-alpha could result in accumulation of S-phase population and upregulation of cyclin-dependent kinase inhibitor (CKI), p27. Moreover, IFN-alpha inhibits DNA synthesis assessed by [H-3] thymidine incorporation and colony formation on soft agar. Immunodepletion of p27 increased CDK2- and cyclin E-associated kinase activities. These data suggest that IFN-a exerts its antiproliferative effects in the neuroendocrine differentiated cell lines by: 1) inhibition of DNA synthesis and colony formation, 2) upregulation on the mRNA and protein expressions of the CKI, p27.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 50 条
  • [31] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    Matsumoto, M
    Furihata, M
    Ishikawa, T
    Ohtsuki, Y
    Ogoshi, S
    BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 256 - 261
  • [32] Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer
    Hives, Mark
    Jurecekova, Jana
    Kliment, Jan
    Grendar, Marian
    Kaplan, Peter
    Dusenka, Robert
    Evin, Daniel
    Vilckova, Marta
    Holeckova, Klaudia Hives
    Sivonova, Monika Kmetova
    CANCER GENOMICS & PROTEOMICS, 2022, 19 (03) : 362 - 371
  • [33] Cyclin E-CDK2 is a regulator of p27(Kip1)
    Sheaff, RJ
    Groudine, M
    Gordon, M
    Roberts, JM
    Clurman, BE
    GENES & DEVELOPMENT, 1997, 11 (11) : 1464 - 1478
  • [34] Regulation of p27(Kip1) by cyclin E-Cdk2
    Roberts, JM
    Sheaff, R
    Clurman, B
    Groudine, M
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 5 - 5
  • [35] Estrogen-induced activation of Cdk4 and Cdk2 during G(1)-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2
    Prall, OWJ
    Sarcevic, B
    Musgrove, EA
    Watts, CKW
    Sutherland, RL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (16) : 10882 - 10894
  • [36] Regulatory role of cAMP on expression of Cdk4 and p27Kip1 by inhibiting phosphatidylinositol 3-kinase in corneal endothelial cells
    Lee, HT
    Kay, EP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (09) : 3816 - 3825
  • [37] Differential association of p21Cip1 and p27Kip1 with cyclin E-CDK2 during rat liver regeneration
    Pujol, MJ
    Jaime, M
    Serratosa, J
    Jaumot, M
    Agell, N
    Bachs, O
    JOURNAL OF HEPATOLOGY, 2000, 33 (02) : 266 - 274
  • [38] The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
    Reynisdottir, I
    Massague, J
    GENES & DEVELOPMENT, 1997, 11 (04) : 492 - 503
  • [39] The MYC-antagonist MAD1 and p27KIP1 cooperate to inhibit cyclin E:Cdk2 activity and promote differentiation of granulocytes.
    McArthur, GA
    Foley, KP
    Ramos, LS
    Eisenman, RN
    BLOOD, 1998, 92 (10) : 672A - 672A
  • [40] Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma
    M Matsumoto
    M Furihata
    T Ishikawa
    Y Ohtsuki
    S Ogoshi
    British Journal of Cancer, 1999, 80 : 256 - 261